Assenagon Asset Management
EWTX icon

Assenagon Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Assenagon Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.8M Buy
+735,202
New +$31.2M 0.03% 355

Other funds holding EWTX

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

Assenagon Asset Management's EWTX Position: Q3 2026 in Review

Assenagon Asset Management opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 735,202 shares worth $29.8M. The stake represents 0.03% of the portfolio and ranks #355 among its holdings.

9 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Assenagon Asset Management held 735,202 shares of Edgewise Therapeutics worth $29.8M as of Q3 2026.
  • Edgewise Therapeutics was a new Assenagon Asset Management position in Q3 2026.
  • Edgewise Therapeutics made up 0.03% of Assenagon Asset Management's portfolio in Q3 2026, its #355 holding.
  • 9 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Assenagon Asset Management's 13F filing for Q3 2026, filed 15 Oct 2026.